LawFuel.com -DLA Piper announced that Zhaoyang “Paul” Li has joined the firm’s Intellectual Property and Technology practice and Patent Prosecution group as a partner in the San Francisco office.
Li focuses his practice on complex IP matters, particularly those involving Chinese companies, including patent prosecution, patent infringement assessment opinions, patent right licensing agreements, patentability, and IP counseling and due diligence. He also handles patent litigation for a variety of private and public companies that work in highly technical areas, including biotechnology, biopharmaceuticals, pharmaceuticals, tissue engineering, telecommunications and electronics, among others.
“The addition of Paul is an important part of our strategy to expand our global patent capabilities, especially in China, where multinational companies have significant and complex IP needs,” said John Allcock global co-chair and US chair of DLA Piper’s Intellectual Property and Technology practice. “The combination of Paul’s legal and scientific background and his history of working with multinational companies will be a great benefit to our clients in US-China patent and life sciences matters.”
Li was also appointed by the US State Department as the US Intellectual Property Rights (IPR) speaker in the Greater China region to promote IPR protection and enforcement. He also serves as a special adviser to the Technology Commercialization Research Center for Nanjing University, which hosts training programs for companies in various Chinese sectors.
“Paul is a tremendous talent and will complement our deep roster of IP and technology practitioners working on the West Coast and in Asia,” said Stephen Cowan, managing partner of DLA Piper’s San Francisco office. “He brings with him a deep pool of contacts, including major Chinese companies, and, combined with the firm’s global network, will be an important part of the range of capabilities we offer clients operating throughout the region.”
Previously a partner at Squire Sanders LLP, Li received his J.D. from Vanderbilt University and a Ph.D. in Chemistry from the University of South Carolina. He also received his B.S. and M.S. in Chemistry from Nankai University in Tianjin, China, and later performed postdoctoral research in organometallic chemistry for the State University of New York at Stony Brook.